If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Allied Minds PLC

24 Nov 2022 10:42

RNS Number : 5087H
Numis Securities Limited
24 November 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Allied Minds PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Allied Minds PLC (Financial Adviser and Corporate Broker)

(d) Date dealing undertaken:

23/11/2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p Ordinary

Purchase

560,048

9.4000 GBX

9.4000 GBX

1p Ordinary

Sale

560,048

9.4000 GBX

9.4000 GBX

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

24/11/2022

Contact name:

Timothy Mitchell

Telephone number:

020 7260 1449

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERBGBDBBSDDGDS
Date   Source Headline
7th Dec 201812:02 pmRNSPrice Monitoring Extension
6th Dec 201812:02 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSHawkEye 360 successful pathfinder satellite launch
12th Nov 20187:00 amRNSSpin Memory series B and commercial partnerships
9th Nov 20185:09 pmRNSBlocklisting Six Monthly Return
9th Nov 20185:05 pmRNSBlocklisting Six Monthly Return
27th Sep 20187:00 amRNSHalf-year Report
24th Sep 20187:00 amRNSSTT announces appointment of Chairman
18th Sep 20187:00 amRNSAllied Minds forms QuayChain subsidiary
10th Sep 20187:00 amRNSFederated Wireless update
10th Sep 20187:00 amRNSHawkEye 360 completes second Series A-3 funding
10th Sep 20187:00 amRNSBridgeSat raises $10.0 million Series B financing
15th Aug 20184:35 pmRNSPrice Monitoring Extension
13th Aug 20187:03 amRNSNotice of Results
13th Aug 20187:00 amRNSHawkEye 360 raises $9.6m in Series A-3 financing
11th Jul 20184:35 pmRNSPrice Monitoring Extension
11th Jul 20187:00 amRNSPrecision Biopsy appoints Chief Operating Officer
2nd Jul 20183:15 pmRNSTotal Voting Rights
26th Jun 20185:17 pmRNSDirector/PDMR Shareholding
19th Jun 20184:54 pmRNSDirector/PDMR Shareholding
19th Jun 20184:48 pmRNSDirector/PDMR Shareholding
19th Jun 20184:38 pmRNSDirector/PDMR Shareholding
12th Jun 201811:12 amRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSDirectorate Change
23rd May 20183:30 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading Statement
16th May 20181:25 pmRNSDirector/PDMR Shareholding
16th May 201811:24 amRNSDirector/PDMR Shareholding
16th May 201810:51 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSFederated Wireless Update
11th May 20189:38 amRNSBlocklisting Six Monthly Return
11th May 20189:31 amRNSBlocklisting Six Monthly Return
1st May 20183:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSAllied Minds leads funding round at TableUp
9th Apr 20188:25 amRNSAllied Minds leads Orbital Sidekick funding round
6th Apr 20187:00 amRNSNotice of AGM and Annual Report
3rd Apr 201811:26 amRNSTotal Voting Rights
22nd Mar 20187:01 amRNSDirectorate Change
22nd Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20187:00 amRNSNotice of Results
1st Mar 20182:17 pmRNSTotal Voting Rights
1st Feb 201810:20 amRNSTotal Voting Rights
22nd Jan 20183:25 pmRNSDirector/PDMR Shareholding
22nd Jan 20183:22 pmRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSCapital Markets Day Materials
17th Jan 20187:00 amRNSAllied Minds: Sale of Percipient Networks
11th Jan 20187:00 amRNSSTT's $22.8m convertible bridge facility
19th Dec 201712:02 pmRNSPrice Monitoring Extension
18th Dec 20177:00 amRNSSciFluor: results of phase 1/2 study of SF0166
30th Nov 201712:12 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.